Purchase Order 36C24226P0262
Award Date 12/30/25
Potential Completion Date 2/1/26
Potential Value $13K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Belle Isle, FL 32809, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs, Veterans Integrated Service Network 2 (VISN 2) awarded a firm fixed-price purchase order to Walgreens Specialty Pharmacy, LLC for the supply of Jynarque 45mg-15mg medication, with a ceiling value of $13,242.99. The contract was awarded on December 3, 2025, with an ultimate completion date of January 2, 2026. Performance will take place in Belle Isle, Florida. This is a non-set-aside acquisition, meaning it was open to all qualified vendors in the competitive...
- This is a $13,242.99 firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract is for the delivery of the medication Jynarque (tolvaptan) to the VA's Veterans Integrated Service Network 2 (VISN 2). The award has no set-aside designation, indicating it is open to all qualified vendors. The performance period runs from the award date of April 30, 2025 through the...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 2 (VISN 2) to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract, valued at $13,242.99, is for the emergency procurement of the medication Jynarque (tolvaptan) to support the VA's healthcare services for veterans. The contract has a period of performance through July 7, 2025 and does not have a set-aside designation,...
- The U.S. Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price purchase order to Walgreens Specialty Pharmacy, LLC in the amount of $12,580.72. The contract is for the delivery of the medication Jynarque (tolvaptan) to treat autosomal dominant polycystic kidney disease. This contract was awarded to Walgreens Specialty Pharmacy as the prime contractor, with no set-aside designation mentioned. The contract period of performance runs through March 19,...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration, specifically the Veterans Integrated Service Network (VISN) 2, to Walgreens Specialty Pharmacy, LLC. The contract is for the delivery of the medication Jynarque (tolvaptan) 45/15mg tablets, which is used to treat autosomal dominant polycystic kidney disease. The contract has a ceiling value of $13,242.99 and a performance period ending on June 18, 2025. The...
- This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 2 to Walgreens Specialty Pharmacy, LLC, a division of the Walgreens retail pharmacy chain, for the supply of Jynarque (tolvaptan) 45/105mg tablets. The contract has a ceiling value of $12,580.72 and a period of performance through October 18, 2024. Walgreens Specialty Pharmacy is the prime contractor on this contract, with no subcontractors or set-aside...
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract is for the supply of the medication Jynarque (tolvaptan), which is used to treat autosomal dominant polycystic kidney disease. The contract has a ceiling value of $83,000.32 and a performance period ending on September 30, 2021. The contract is not set aside for any specific business type....
- This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract is for the delivery of the medication Jynarque (tolvaptan) tablets to the VA's Veterans Integrated Service Network 2 (VISN 2) facilities. The contract has a ceiling value of $13,242.99 and a period of performance through August 27, 2025. The contract does not...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Walgreens Specialty Pharmacy, LLC, a subsidiary of the Walgreens retail pharmacy chain. The contract is for the emergency supply of the prescription drug Jynarque (tolvaptan) for $13,242.99, with a completion date of August 4, 2025. Jynarque is used to treat autosomal dominant polycystic kidney disease. This non-set-aside contract was awarded through the VA's Veterans Integrated Service Network 2...
- This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 to Walgreens Specialty Pharmacy, LLC, a for-profit subsidiary of the Walgreens retail pharmacy chain. The $13,242.99 contract is for the emergency supply of the prescription medication Jynarque 45 mg - 15 mg to the Northport VA Medical Center, with a completion date of June 6, 2025. The contract has no set-aside designation, indicating it was open to all qualified...